News

Innovative Alzheimer therapy: A new license agreement between BioArctic and Eisai on back-up program to BAN2401

September 28, 2015 - News

BioArctic Neuroscience AB announces today that a new license agreement has been signed between BioArctic and the Japanese pharmaceutical company Eisai Co., Ltd.

BioArctic Receives Extended Funding from VINNOVA

September 1, 2015 - News

In August 2015, VINNOVA announced that BioArctic Neuroscience AB together with the Ångström Laboratory, Department of Engineering Sciences, Uppsala University, and Psilox AB were granted extended ...

BioArctic Neuroscience Parkinson’s disease program receives grant from EU

September 1, 2015 - News

The Swedish biopharmaceutical company BioArctic Neuroscience AB is developing a novel disease modifying treatment for Parkinson´s disease with potential to improve the quality of life for ...

BioArctic Neuroscience Parkinson’s disease program receives grant from VINNOVA

June 15, 2015 - News

The Swedish biopharmaceutical company BioArctic Neuroscience AB is developing a novel disease modifying treatment for Parkinson´s disease with potential to improve the quality of life for ...

BioArctic Neuroscience has been nominated to SwedenBIO Award

June 3, 2015 - News

BioArctic Neuroscience has been nominated to SwedenBIO Award 2015. Each year SwedenBIO Award is awarded to a company that serves as a role model in the ...

Innovative Alzheimer therapy: A new Research Agreement between BioArctic and Eisai initiated

May 19, 2015 - News

BioArctic Neuroscience AB announces today that a new research agreement has been initiated between BioArctic and the Japanese pharmaceutical company Eisai. The research will lead to ...

2nd US patent granted on therapeutic antibodies for Parkinson’s disease

April 2, 2015 - News

On March 3rd 2015, the US patent office granted BioArctic a US patent (US 8, 968, 734 B2) covering therapeutic and diagnostic antibodies for Parkinson’s ...